Navigation Links
Martek Announces Settlement of Class Action Lawsuit
Date:12/10/2007

COLUMBIA, Md., Dec. 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it has entered into a tentative settlement of all claims in the securities class action litigation filed in the United States District Court for the District of Maryland alleging, among other things, violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934. The settlement will result in the dismissal of the claims against Martek and all other defendants, subject to final court approval.

The proposed settlement of the class action will include a cash payment to the settlement fund of $6 million, all of which will be paid by the Company's insurer. The parties anticipate filing in the near future a motion in the federal court asking for approval of the proposed settlement, which is required before the settlement becomes effective and final. No assurances can be given that the settlement ultimately will be approved by the court.

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM)(arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot contro
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
8. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... President ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ ... Future study (MTF) -- the largest survey on teen ... graders -- underscores that teens, intentional abuse of prescription ... cause for concern, with an alarming number of young ... ,, Teen Abuse of Medication Continues ...
(Date:12/14/2009)... Dec. 14 The Hemophilia Federation of ... labor issues involving the Teamsters Local 929 and ... The national blood system depends on skilled workers ... blood is distilled into products such as clotting ... Willebrand disease. ,, The Division of Blood ...
(Date:12/14/2009)... treated, hadn,t spread, study finds , , MONDAY, Dec. 14 ... of death in male colon cancer survivors, researchers report. ... 668 men who,d been treated for stage I, stage ... spread (nonmetastatic cancer). Every two years, the men were ... and disease diagnoses, as well as their physical activity. ...
(Date:12/14/2009)... may also offer some protection, study finds, , , MONDAY, ... people who can,t start their morning without a cup ... decrease the risk of developing type 2 diabetes. ... also found the more coffee you drink, the lower ... associated with a 7 percent reduction in the risk ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... Obese and overweight men who are diagnosed with prostate cancer ... actually have a more aggressive// case of the disease than ... by a Duke University Medical Center researcher. ,The ... obese and overweight men to receive inadequate or inappropriate treatment ...
... LEXINGTON, Ky. − When studying a new blood thinner, one ... a slight increase in minor bleeding—nose bleeds and bruising,// an ... the leading cause of heart attack and stroke. While potentially ... bleeding in some patients, requiring frequent monitoring of blood levels. ...
... interventions on their children, hoping life would become that much bearable// ... debate in the US. ,Ashley of Seattle was born ... only three months old. , She is sensate, she ... to enjoy music. But she can barely move and will never ...
... White House Press Secretary Tony Snow has bad news. His ... sadly resurfaced//. ,Snow was treated with chemotherapy ... prevent satellite growths of tumors that could be metastatic. Yet ... pelvic area, doctors discovered additional tumors in his liver. ...
... to control high blood pressure and new drugs that ... researchers have designed two promising new cardiovascular treatment approaches, ... form to lower high blood pressure and a therapeutic ... function. ,In the process, they have ...
... Fractures are a common injury among children, yet the ... special musculoskeletal problems// of children is decreasing nationwide. The ... in adults. Specialized knowledge and training is needed to ... orthopedic surgeons at New York’s Hospital for Special Surgery ...
Other Medicine News:Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Debate in US: Who Should Decide for Disabled People? 2Health News:White House Press Secretary to Battle Second Round of Colon Cancer 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
(Date:12/14/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... to help maintain the bone health of prostate ... therapy (ADT). Nearly two million men are ... that, while highly effective and considered the "gold ... man,s risk for osteoporosis. ,, As part of ...
(Date:12/14/2009)... DOVER, Del., Dec. 14 Ohr Pharmaceutical Inc. ... selected Allen & Caron Inc, headquartered in Irvine, ... London, as its agency for investor relations and ... stage biotechnology company focused on developing advanced drugs ... pipeline compounds with potentially large, global markets: OHR/AVR118 ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3SPECT provides high quality images of small tumors 48912 1Pregnant women at high risk of complications from H1N1 influenza 48908 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 2Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 3Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 4
... Israel, February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), ... that it has concluded a proof of concept,study ... its,proprietary technology. Eight healthy volunteers came for two ... The insulin suppositories showed rapid insulin absorption ...
... PDUFA Date for Cinryze for Acute HAE Indication is June ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... priority review for Cinryze C1 Inhibitor (human) as a treatment ... Biologics License Application (sBLA), submitted to the FDA on December ...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
... TraceMasterVue is a cutting-edge ECG ... thin-client functionality and convenient, web-based ... administrative and information technology (IT) ... lower costs, and improved patient ...
Medicine Products: